Results 271 to 280 of about 189,149 (342)

Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background As Parkinson's disease (PD) progresses, motor fluctuations become increasingly difficult to manage with oral medications. Foslevodopa/foscarbidopa (LDp/CDp), delivered as a continuous 24‐h/day subcutaneous infusion, offers continuous levodopa delivery and stable plasma levodopa levels that reduce motor fluctuations. LDp/CDp has been
K. Ray Chaudhuri, Bruno Bergmans, Eric Freire‐Alvarez, Lucie Hopes, Drew S. Kern, Robert S. Kirsner, Giulia Lazzeri, Pedro Mendes‐Bastos, Noriko Nishikawa, Per Odin, Karolina Poplawska‐Domaszewicz, Rajesh Pahwa, Yuval Ramot, Klaus Seppi, Tobias Warnecke, Robert Wiggins, Megha B. Shah, Pavnit Kukreja, Bjoern Fritz, Koray Onuk, Stuart H. Isaacson   +20 more
wiley   +1 more source

Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases. [PDF]

Schizophr Bull
Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani T, Preller KH, Taylor JP, Waters F, Winston BS, Leptourgos P.   +12 more
europepmc   +1 more source

Keeping generative artificial intelligence reliable in omics biology. [PDF]

Patterns (N Y)
Burger T.
europepmc   +1 more source

Capturing Behavioral Symptoms in Huntington's Disease Using the Huntington's Disease‐Behavioral Questionnaire

Movement Disorders Clinical Practice, EarlyView.
Abstract Background The Huntington's Disease Behavioral Questionnaire (HD‐BQ) captures behavioral symptoms arising from cognitive, psychiatric, and functional domains. Recognizing the high prevalence of anosognosia in HD, the HD‐BQ incorporates patient‐ and companion‐reported versions.
Siena Rigatuso, Krisha Bagga, Shelby Hughes, Japleen Kaur, Paul E. Gilbert, Jody Corey‐Bloom   +5 more
wiley   +1 more source

Virtual reality for visions (VRV): a proof-of-concept study examining the development of a new treatment for distressing visual hallucinations in people with psychosis. [PDF]

BMJ Open
Dudley R, Sargeant S, Gibbs C, Prentice L, McCartney L, Aynsworth C, Maskey M, Skeggs A.   +7 more
europepmc   +1 more source

A New Phenotype–Genotype Correlation for FIG4 and Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Iro Boura, Panayiotis Mitsias, Sofia Erimaki, Efrosini Papadaki, Cleanthe Spanaki   +4 more
wiley   +1 more source

Analysis of AQP4 SNPs and Their Association With REM Sleep Behavior Disorder and Hallucinations in Parkinson's Disease. [PDF]

Mol Neurobiol
Agliardi C, Guerini FR, Zanzottera M, Bolognesi E, Meloni M, Saibene FL, Zangaglia R, Sturchio A, Casali C, Di Lorenzo C, Navarro J, Minafra B, Clerici M.   +12 more
europepmc   +1 more source

AI Autonomous Evolution Series — Part I Suppressing Hallucination for Trustworthy LLMs: A Layer–Knot Framework and HR/GR/CR Metrics Approach

DAEDO JUN
openalex   +1 more source

Emotional processes in understanding and treating psychosis [PDF]

, 2016
Gumley, Andrew, McLeod, Hamish, Rossell, Susan, Thomas, Neil   +3 more
core